Strumento inattivo

Altre lingue Can B Corp. Other OTC

Azioni

CANBD

US13470W1036

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Can B Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	20/05
Can B Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	15/04
Can B : New Financial Obligation - Form 8-K	21/03
Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million	11/03
Can B Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/11
Can B Corp. Expects Nearly $500,000 Annual Savings With Successful Completion of Move of Pure Health Products From Lacey, WA to Colorado	10/10/23
Can B Corp. Announces its Move and Consolidation of its Pure Health Product Operations from Lacey, WA to Colorado	10/10/23
Can B Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	21/08/23
Can B Corp. Secures 1.8 Million Pounds of Biomass for Awarded Contract With One Bad Moon Rising	20/07/23
Can B Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	22/05/23
Can B Corp. Reports Growth of 45% to Company All-Time High $6.7 Million Annual Revenue	19/04/23
CAN B CORP Management's Discussion and Analysis of Financial Condition and Results of Operation (form 10-K)	17/04/23
Can B Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	17/04/23
Can B Corp. Auditor Raises 'Going Concern' Doubt	17/04/23
Can B Corp. Completes Corporate Debt Restructuring to Position for Uplisting to National Securities Exchange	15/03/23
CAN B CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities (form 8-K)	09/03/23
Can B Corp. announced that it has received $1.55 million in funding	02/03/23
Can B Corp. announced that it expects to receive $1.55 million in funding	27/02/23
Can B Corp. Reports Growth of 51% to $2.9 Million Revenue for Third Quarter 2022, the Highest Quarterly Revenue in Company History	22/11/22
CAN B CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	21/11/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Can B Corp. Other OTC

Azioni

CANBD

US13470W1036

Altre lingue

Filtri